Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money. Today we look at a noteworthy recent insider buy.
And at Repros Therapeutics (NASDAQ:RPRX), there was insider buying on Thursday, by Chief Financial Officer Katherine Anderson who bought 1,000 shares for a cost of $23.77 each, for a trade totaling $23,770. Before this latest buy, Anderson made one other purchase in the past twelve months, buying $11,890 shares at a cost of $11.89 a piece. Repros Therapeutics is trading down about 1.6% on the day Monday. Anderson was up about 5.0% on the purchase at the high point of today's trading session, with RPRX trading as high as $24.96 at last check today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.